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A B S T R A C T
Purpose: We aimed to determine the incidence and case-fatality of ﬁrst-ever status epilepticus (SE)
among the general population living in La Reunion Island, a French overseas territory in the Indian Ocean
near Madagascar.
Methods: We recruited cases (1st July 2004–30th June 2005) in a population-based manner using
neurology, neurosurgery, electroencephalogram, emergency, paediatric and neuroradiology services;
emergency medical aid service; emergency and admission service of private and public clinics;
neurologists (public and private); private paediatricians and practitioners of various rural hospitals. All
cases had an electroencephalogram (EEG) and were assessed by an epileptologist. Standard deﬁnition
and classiﬁcation schemes were used. Those with known epilepsy were not part of this analysis.
Results: Sixty-ﬁve cases (males: n = 41, 63.1%) had epileptologist-conﬁrmed SE, with 38.5% (n = 25)
being >60 years of age. Global incidence rate was 8.52/100 000 (95% conﬁdence interval 6.5–10.5). A
bimodal age distribution with high frequency and incidence among young (<10 years age) (frequency:
12.3%; incidence 6.6/100,000) and aged (>60 years) (frequency: 40.0%; incidence 35.0/100,000) was
observed. We found that 60%, 32.3%, 6.7% had convulsive, partial and non-convulsive SE respectively (1%
remained unclassiﬁed). Of the cases identiﬁed, 44.6%, 38.5%, 16.9% had unprovoked, provoked or
cryptogenic seizures respectively. The most important aetiological factors identiﬁed included: stroke
(27.7%), alcoholism/toxicity (18.5%), cryptogenic (16.9%), infections (10.8%). Mortality was 18.5%.
Conclusion: The incidence of SE incidence in La Reunion Island was lower than that described elsewhere.
The status type was found to be dependent on aetiology and age. The study conﬁrms that SE is more
frequent in men and in older adults and is associated with signiﬁcant short-term case mortality.
 2014 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.
Contents lists available at ScienceDirect
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Status epilepticus (SE) is a serious neurological condition of
prolonged or repetitive seizures and has been investigated in few
populations such as UK, Switzerland, and Italy1–4 etc. Its incidence
varies considerably in prospective (10.3–41/100,000)4–6 and
retrospective (6.2–18.3/100,000) studies.7,8 Thus, in addition to* Corresponding author at: Institut de Neuroe´pide´miologie Tropicale (UMR
1094), Faculte´ de Me´decine, 2, rue du Dr Marcland, 87025 Limoges, Cedex,
France. Tel.: +33 5 55 43 58 20; fax: +33 5 55 43 58 21.
E-mail address: preux@unilim.fr (P.-M. Preux).
http://dx.doi.org/10.1016/j.seizure.2014.06.009
1059-1311/ 2014 British Epilepsy Association. Published by Elsevier Ltd. All rights restudy-speciﬁc differences (e.g. different deﬁnition), underlying
characteristics of each population could contribute to these
differences in incidence rate.3 La Reunion is a French overseas
territory and the population here is perceived to be different than
in Metropolitan France9–12 especially with reference to SE-speciﬁc
aetiologies including alcoholism, trauma, cerebrovascular event,
metabolic abnormalities, infection etc., which together constitute
about 50% of SE cases.13 In any case, the risk for having SE is said to
be higher in non-Caucasians.5 These factors suggest that a higher
SE incidence could be expected in this population. Furthermore,
the risk for high fatality as observed in other populations
(immediate and short-term, i.e. during hospitalisation or within
30 days of SE, 7.6–22%) or long-term, within 10 years of initialserved.
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this population as well.3 So far, there has been no population-based
study on SE in La Reunion. We conducted the ﬁrst study of status
epilepticus to prospectively examine the incidence and case-
fatality of a ﬁrst episode of status epilepticus among population of
all ages in La Reunion.
2. Methods
2.1. Study area and population
Reunion Island is a tropical French overseas territory
(n = 763,204, in 2004, 50.9% females) situated in the South Indian
Ocean (55.368E/21.068S) with a total area of 2.512 km.2 It is
located about 200 km south west of Mauritius and 9200 km from
Paris. The majority of the population is ethnically mixed (53%) or
European (23%) and the rest have diverse origins predominantly
Indian (Malabars, Muslims, Punjabi etc.) and other minority
groups belonging to China and African tribes. The active
population works essentially in the tertiary sector and the
unemployment rate is 3-fold more (29.5%) than in metropolitan
France (8.9%).14 The level and access to care (practitioners’ and
specialists’) including electroencephalography (EEG), computed
tomography (CT), and magnetic resonance imaging (MRI) is of
high standards and similar to that in metropolitan France.
Reunion Island has four public hospital groups situated in the
North (Saint Denis), South (Saint Pierre), East (Saint Benoıˆt), and
the West (Saint Paul). The neurology and paediatric services are
available in South and North public hospital groups. There is also a
private neurology facility in Saint Denis. The Reunion Island is
largely urban in nature and only 6% of the population is rural
(2009 data).
2.2. Case ascertainment and data management
For this, we conducted a prospective, observational, and
multicentre epidemiologic study to identify patients with SE
between 1st July 2004 and 30th June 2005. To ascertain all SE
episodes as completely as possible during this 1 year period,15
extensive case collection was done under the auspices of Re´union
Association for Research in Neurology, Neurosurgery and Neuro-
pathology; Regional Administration of Sanitary and Social Affairs;
Regional Hospital Agency; and French Foundation for Research on
Epilepsy and island health authorities of three divisions. Cases
were recruited prospectively from neurology services of Saint
Pierre hospital (South of Island) and Saint Denis hospital (North of
Island); neurosurgery service of Saint-Pierre Hospital; EEG service
of Saint Pierre, Saint-Denis et Saint Paul hospitals; emergency,
paediatric and neuroradiology services of four primary hospitals;
emergency medical aide service; emergency and admission
services of clinics; neurologists (eight in public practice and six
in private practice); private paediatricians and practitioners of
various rural hospitals. The study panel comprised of one
neurologist and one epileptologist located in the North and South
Hospital groups. A staff meeting was organised every 3 months to
manage all included cases. An epileptologist (P. Jallon) coordinated
with all EEG laboratories and other neurologists to ensure the
completeness of cases who also reviewed all clinical and EEG data.
The following were considered as EEG abnormalities: slow waves
(local or generalised) and paroxysms (local or generalised). The
conﬁdentiality of the data was maintained and the study protocol
was pre-approved by the National Committee for the protection of
computerised data (Commission Nationale Informatique et Lib-
erte´) and the local ethics committee. A written informed consent
was obtained from all included cases or their proxies.2.2.1. Deﬁnition and classiﬁcation of SE
We deﬁned SE as a single clinical seizure lasting >30 min or
repeated seizures over a period of >30 min without intervening
recovery of consciousness.16 All patients alive >30 days after onset
of SE were regarded as survivors. SE was classiﬁed using Treiman
Scheme17 and was classiﬁed clinically as convulsive (primary and
secondary generalised included), non-convulsive (subtle, typical
and atypical absence and complex partial included) and partial
(simple partial included) SE.18 The epidemiological classiﬁcation
included provoked, unprovoked symptomatic and cryptogenic.
The classiﬁcation was performed by an epileptologist based on the
clinical and EEG and imaging data.
2.3. Non-inclusion criteria
Patients who had newly-diagnosed unprovoked epileptic seizure
lasting <30 min or febrile, neonatal, or non-epileptic seizures,
incomplete medical charts, with known epilepsy, residence outside
Reunion Island and diagnosis made outside the study period.
3. Statistical analysis
The incidence (age-, sex-speciﬁc) and frequency (age-speciﬁc)
of SE was calculated. We also calculated frequency of various
aetiologies for provoked and unprovoked SE. Conﬁdence intervals
95% (95% CI) were calculated using a Poisson distribution. Analyses
were performed with Statview v5.0 software (SAS Institute, Cary,
NC, USA). Age-standardised incidence rate was estimated by using
direct method to European population. We used 5% statistical
signiﬁcance for statistical calculations.
4. Results
One thousand and six suspected cases of newly-diagnosed
unprovoked epileptic seizure were obtained from the island during
the study period, 766 had newly-diagnosed epileptic seizure,15 and
a total of 65 cases out of 1006 met the inclusion criteria of being
diagnosed as SE. These cases were conﬁrmed by epileptologists.15
The febrile (n = 128), neonatal (n = 15), non-epileptic (n = 46)
seizures, incomplete medical charts (n = 24), residence outside
Reunion Island and diagnosis made outside the study period
(n = 27).
4.1. Incidence rate
Sixty ﬁve SE cases (n = 41, 63.1% males) yielded a global
incidence rate of SE of 8.52/100,000 (95% CI 6.5–10.5) in this
population. The age-standardised incidence rate using direct
method (to European population) was 10.8/100,000 (95% CI 8.9–
12.9). The sex-speciﬁc and age-speciﬁc incidence rates are
presented in Table 1. Most frequent age-group was 6th decade
(23.0%) with a high frequency among those <10 years and 60
years. Two bimodal incidence peaks were 1st decade (6.6/100,000)
and 6th decade (35.0/100,000), Table 1. The peak of incidence rate
was higher in males (54.5/100,000) than females (35.8/100,000)
and was earlier (6th decade) than females (7th decade). The 1st-
decade incidence in male children was nearly double (8.6/100,000)
of that in female children (4.5/100,000).
4.2. Classiﬁcation and aetiologies
Sixty percent (60.0%) had convulsive SE and 32.3% and 6.7% had
partial and non-convulsive SE and 1% cases remained undeter-
mined. The epidemiologic classiﬁcation yielded 44.6% SE cases
with unprovoked symptomatic seizures, 38.5% with provoked
seizures and 16.9% with cryptogenic seizures. Overall, two major
Table 1
Age and sex-speciﬁc incidence (I) rates of status epilepticus.
Age group Males Females Total
N I/100,000 N I/100,000 N I/100,000
0–9 years 6 8.6 3 4.5 9 6.6
10–19 years 3 4.2 1 1.4 4 2.9
20–29 years 3 5.3 0 0.0 3 2.6
30–39 years 2 3.4 2 3.2 4 3.3
40–49 years 5 9.6 2 3.7 7 6.6
50–59 years 7 21.1 6 17.6 13 19.3
60–69 years 11 54.5 4 17.6 15 35.0
70–79 years 3 29.4 5 35.8 8 33.1
80 years 1 26.8 1 13.1 2 17.6
Total 41 10.9 (95% CI 7.6–14.2) 24 6.2 (95% CI 4.0–8.4) 65 8.5 (95% CI 6.5–10.5)
CI, conﬁdence interval.
D. Bhalla et al. / Seizure 23 (2014) 769–773 771aetiologic factors were (Table 2): stroke (27.7%) and alcoholism/
toxicity (18.5%). For complete picture on aetiologies, please refer to
Table 2.
4.3. Management of status epilepticus
4.3.1. Complementary examinations
The EEG was performed in all SE cases. 78.5% had abnormal EEG
and it was not interpretable in 7.7% cases, remaining had normal
EEG. The CT scan was done in 80.0% of cases and 67.3% had
abnormal CT scans of which 3/4th had lesions and 1/4th had no
lesions. The Magnetic Resonance Imaging (MRI) of 33.8% cases
yielded abnormal ﬁndings in 68.2% of cases of which 2/3rd had
lesions and 1/3rd had no lesions.
4.3.2. Case locations and diagnostic delay in SE cases
More patients were reported from the Southern centre (Saint
Pierre) (61.5%). The diagnostic delay was very short in majority of
cases (83.1% within 24 h).
4.3.3. Events as a direct consequence of SE
About76.9%had noevent(s)as adirectconsequence of SE.The case-
fatality in our cohort was 18.5% whereas 4.6% had a physical injury(s).
4.3.4. Treatment
Phenytoin in 44.6% cases (in combination with benzodiazepine
in 69% cases); sodium valproate was used in 30.7% cases (and in
combination with benzodiazepine in 75% cases); benzodiazepine
in 30.7% cases (monotherapy in 20% cases) and phenobarbital in
15.4% cases (in combination with benzodiazepine in 30% cases).
Overall, 84.2% cases were having benzodiazepines as either single
or in combination therapy.
5. Discussion
Status epilepticus is a medical emergency that is associated
with high mortality. We present here the results of a ﬁrstTable 2
Aetiological distribution among status epilepticus cases.
Number Aetiologies 
1 Stroke 
2 Alcohol and toxic 
3 Cryptogenic 
4 Infections 
5 Metabolic or autoimmune 
6 Cranial trauma, including post-surgical 
7 Undetermined or multiple 
8 Tumour population-based study on status epilepticus in La Reunion that
evaluated incidence and case-fatality rates in a population outside
Europe or US which makes for majority of studies on SE. We
yielded an overall incidence rate of 8.52/100,000 which is lower
than rates from other Western populations that ranged from 10.3
to 41.0/1,000,005. In non-western populations, the incidence
studies that included both convulsive and non-convulsive forms
are rare. Two studies however show a frequency of 11.0% for non-
convulsive SE19 in India, and an incidence of 35.0/100,000 in
Kenya.20 The overall SE incidence rate in some black populations
may reach 60.0/100,00021 which is much higher than that
observed in our study. A lower incidence (age-standardised) rate
to European population further indicates that the incidence is
likely to be lower in Reunion Island than Europe. However we
cannot completely ignore the possibility that some proportion of
cases might have been missed due to the restricted inclusion
criteria we had adopted.
Case ascertainment, and consequently incidence, may be
partially inﬂuenced by the presence of specialist care22 or under-
diagnosis of non-convulsive forms or lack of hospitalisation and
clear reporting of seizure duration.23 Under-ascertainment of cases
in our study is less likely since the region is geographically self-
contained and good medical facilities are available in close
proximities thus loss of cases due to this reason seemed less likely.
Use of EEG laboratories as a case-source has been done previously24
and proven to be effective since anyone suspected of having an
epileptic seizure would soon undergo an EEG recording to ascertain
the diagnosis. However, this ascertainment method is more suitable
for populations where such facility is readily available. In any case,
we used many case sources that make under case-ascertainment
less likely. We had more frequent reporting of SE (61.5%) in South of
the Island which could be due to the presence of greater number of
reanimation services and the only neurosurgical reanimation
service of the La Reunion Island.
Inﬂuence of referral bias on incidence estimate seem unlikely
since all neurology service-points of the Island were engaged in
this study and SE is an emergency situation and it is less likely that
patient would not seek any care at all. La Reunion Island has a wellUnprovoked Provoked Total
n = 16, 40.0% n = 2, 8.0% n = 18, 27.7%
n = 6, 15.0% n = 6, 24.0% n = 12, 18.5%
n = 11, 27.5% n = 0, 0.0% n = 11, 16.9%
n = 2, 5.0% n = 5, 20.0% n = 7, 10.8%
n = 3, 7.5% n = 4, 16.0% n = 7, 10.8%
n = 1, 2.5% n = 3, 12.0% n = 4, 6.1%
n = 1, 2.5% n = 3, 12.0% n = 4, 6.1%
n = 0, 0.0% n = 2, 8.0% n = 2, 3.1%
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is likely to be different than other tropical populations where
medical care facilities may not be as strong as is in La Reunion
Island. Furthermore, referral bias due to urban-rural differences is
also less likely here as well since the majority of the population of
the Island is urban in nature (only 6% are rural).
In our study, 60.0% had convulsive SE and 32.3% and 6.7% had
partial and non-convulsive SE. This predominance of convulsive
form is well recognised25 and nearly half of the SE cases can be
expected to be convulsive in nature although its relative
frequency is difﬁcult to establish since various types of status
are not speciﬁed separately in most series.26 Incidence rate of
convulsive SE in African origin population20 is higher than a
European population.27 Non-convulsive SE is less frequently
reported although it is not rare and could be due to its under-
diagnosis since the epileptic nature of the clinical features is not
usually readily recognised and EEG may not be available for
hours. In studies that included both forms of SE, non-convulsive
SE can be observed in 5–6% of cases although frequency up to
23.0% is also reported.3 We yielded slightly higher frequency
(7%) of non-convulsive cases. This variation in frequency could
be due to differences in study characteristics3 or due to the fact
that diagnosis and EEG was readily conducted in most cases
(83.1% within 24 h). It is to note that we had EEG done in all of our
cases. Furthermore, the frequency of partial non-convulsive SE is
much higher in our study than other populations28 although
other studies report that SE of partial onset accounts for the
majority of episodes.5 However the differences could be due to the
difference in distribution of different aetiologies or the observa-
tion that in elderly people (as in our study sample), the relative
frequency of simple and complex partial forms of SE also
increases8 and that focal epileptic activity tends to generalise
less often in old age.29
While different classiﬁcation schemes and training of practi-
tioners may introduce bias towards frequency of different SE types,
we controlled these by using classic Treiman Scheme17 that is
believed to be more useful than other schemes for emergency
treatment decisions; and giving diagnostic and classiﬁcation task
to a very senior epileptologist. Non-convulsive forms are consid-
ered to form one-quarter of all SE cases30 and this estimate is not
very different in our study.
In our study, as expected, there were age–gender speciﬁc
differences in the incidence of SE. In general, incidence showed a
strong age-dependency5 with bimodal distribution and with two
peaks at 1st and 6th decade of life. Males (10.9/100,000) had a
higher incidence than females (8.52/100,000), which matches with
US and some European studies3 but is in contrast to two South
European studies2 that reported female predominance. This
difference could be due to different age–sex composition or higher
possibility for stroke, cranial trauma and alcoholism in males or
gender difference in seizure threshold or plain hormonal inﬂuence
in seizure termination.31 Our rate of incidence in elderly than in
young adults (20–59 years) matches with the observations from
other studies.5
Furthermore, cerebrovascular disease was the main aetiology
(27.7%) in our study which is similarly observed as in other
studies3 or metabolic derangement (10.8%) which is less frequent
than other populations.28 In contrast to other studies such as in
China,28 alcohol-related SE was a common cause in our study and
could be due to the lower alcohol consumption and dependence in
some communities. This could be another reason for the high
frequency of generalised convulsive SE in our study in contrast to
other populations.7 Idiopathic cases may account for 3–18% of
cases28which was much lower in our study (6.1%) and could be due
to the fact that all cases were evaluated, in a timely manner, by
very experienced epileptologist and neurologists. Due to numberof factors (e.g. small and isolate geographical area, good medical
facilities), the delay in diagnosis and treatment onset was <24 h
in most cases in our cases which is often not observed in other
large populations28 which may expect a delay in diagnosis in
30% of cases. This is important since delay in reaching hospital
(e.g. distance to hospital) may lead to increased duration of SE
and consequently high neurological damage and mortality.32
Treatment may affect outcome by reducing the seizure length
and consequential complications. Two studies reported that a
signiﬁcant proportion of patients were not treated prior to arrival to
hospital.4,6 This is signiﬁcant, as delayed treatment may increase the
frequency of SE33 and thus could be another reason for low incidence
of SE in our population. Benzodiazepines are 1st line treatment in SE
cases34 and was used in 84.2% of our cases mostly in combination
with other treatments. Even though benzodiazepines are recom-
mended 1st line treatment, it is clinically inadequate for about 1/3rd
of cases.34 The signiﬁcance of efﬁcacy of valproate in treating SE may
deserve more detailed evaluation which was beyond the scope of
this survey; although valproate can be used in wide range of patient
population and SE types.35 It also reportedly has low incidence of
side effects.36
SE although was less frequent on this island we experienced a
high (18.5%) short-term fatality. This is despite the short diagnostic
delay in most case (83.1% within 24 h) and absence of any event(s)
as a direct consequence of SE in most (76.9%) of our cases. Our
fatality rate is similar to African-American populations elsewhere
(17%)5 but higher22 or lower than2 some Caucasian populations.
The short-term mortality (<30 days) in the literature however
varies from 7.6 to 33%.3 This high mortality rate could be due to the
high proportion of aged population (59%, Table 1) in our sample or
could be as a direct consequence of SE since a study showed similar
rate of mortality (16%) as a direct consequence of SE.37 Another
reason could lie in the nature of aetiologies. Stroke was the major
aetiological factor in our study as elsewhere38 and could be a
possible factor for high mortality in this population.39 Two studies
dealing with SE in stroke patients reported mortality rates of
48.3%37 and 53.0%.40 A recent study showed that a relatively poor
outcome occurs when the underlying cause is cerebrovascular
disease.41 Moreover, high mortality among SE patients is also
associated with organic brain disease42 or stroke43 as compared
with those patients with no underlying pathology emphasising the
possible synergistic effect of SE and a destructive brain lesion such
as stroke, alcoholic organic brain disease, infections or cranial
trauma as these were signiﬁcant aetiologies in our study sample as
well.
6. Conclusions
We conclude that the incidence of SE in La Reunion Island is
lower than that observed in other population-based cohorts. The
status type is dependent on aetiology and age and conﬁrms that
SE is more frequent in men and the elderly and is associated
with a signiﬁcant short-term case-fatality. Stroke and alcohol-
ism were most important SE-related aetiologies and matches
with the high frequency of these disorders in general popula-
tion. Therefore, patients with stroke should be considered for an
EEG in any case of unexplained changes in consciousness. Lastly,
expected demographic changes of the population may further
inﬂuence the incidence of SE in La Reunion Island. SE was
predominantly in aged population and it is likely that age-
related alterations in renal and hepatic functions, co-morbid
conditions or adverse medication effects etc. may have some
measurable role to play in facilitating the occurrence of SE.
These ﬁgures however provide an important baseline for
surveillance of this disorder in this population.
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